{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:11:37Z","timestamp":1792033897288,"version":"4.4.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012317","name":"University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Charcot-Marie-Tooth disease (CMT) is one of the most common and genetically heterogeneous inherited neurological diseases, with more than 130 disease-causing genes. Whole genome sequencing (WGS) has improved diagnosis across genetic diseases, but the diagnostic impact in CMT is yet to be fully reported. We present the diagnostic results from a single specialist inherited neuropathy centre, including the impact of WGS diagnostic testing.<\/jats:p>\n                  <jats:p>Patients were assessed at our specialist inherited neuropathy centre from 2009 to 2023. Genetic testing was performed using single gene testing, next-generation sequencing targeted panels, research whole exome sequencing and WGS and, latterly, WGS through the UK National Health Service. Variants were assessed using the American College of Medical Genetics and Genomics and Association for Clinical Genomic Science criteria.<\/jats:p>\n                  <jats:p>Excluding patients with hereditary ATTR amyloidosis, 1515 patients with a clinical diagnosis of CMT and related disorders were recruited. In summary, 621 patients had CMT1 (41.0%), 294 CMT2 (19.4%), 205 intermediate CMT (CMTi, 13.5%), 139 hereditary motor neuropathy (HMN, 9.2%), 93 hereditary sensory neuropathy (HSN, 6.1%), 38 sensory ataxic neuropathy (2.5%), 72 hereditary neuropathy with liability to pressure palsies (HNPP, 4.8%) and 53 \u2018complex\u2019 neuropathy (3.5%). Overall, a genetic diagnosis was reached in 76.9% (1165\/1515). A diagnosis was most likely in CMT1 (96.8%, 601\/621), followed by CMTi (81.0%, 166\/205) and then HSN (69.9%, 65\/93). Diagnostic rates remained less than 50% in CMT2, HMN and complex neuropathies. The most common genetic diagnosis was PMP22 duplication (CMT1A; 505\/1165, 43.3%), then GJB1 (CMTX1; 151\/1165, 13.0%), PMP22 deletion (HNPP; 72\/1165, 6.2%) and MFN2 (CMT2A; 46\/1165, 3.9%). We recruited 233 cases to the UK 100 000 Genomes Project (100KGP), of which 74 (31.8%) achieved a diagnosis; 28 had been otherwise diagnosed since recruitment, leaving a true diagnostic rate of WGS through the 100KGP of 19.7% (46\/233). However, almost half of the solved cases (35\/74) received a negative report from the study, and the diagnosis was made through our research access to the WGS data. The overall diagnostic uplift of WGS for the entire cohort was 3.5%.<\/jats:p>\n                  <jats:p>Our diagnostic rate is the highest reported from a single centre and has benefitted from the use of WGS, particularly access to the raw data. However, almost one-quarter of all cases remain unsolved, and a new reference genome and novel technologies will be important to narrow the \u2018diagnostic gap\u2019.<\/jats:p>","DOI":"10.1093\/brain\/awae064","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T03:23:48Z","timestamp":1710386628000},"page":"3144-3156","source":"Crossref","is-referenced-by-count":56,"title":["Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-2683","authenticated-orcid":false,"given":"Christopher J","family":"Record","sequence":"first","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0511-6515","authenticated-orcid":false,"given":"Menelaos","family":"Pipis","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Skorupinska","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Blake","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"},{"name":"Department of Clinical Neurophysiology, Norfolk and Norwich University Hospital , Norwich NR4 7UY , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Poh","sequence":"additional","affiliation":[{"name":"Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-7132","authenticated-orcid":false,"given":"James M","family":"Polke","sequence":"additional","affiliation":[{"name":"Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Eggleton","sequence":"additional","affiliation":[{"name":"Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Nanji","sequence":"additional","affiliation":[{"name":"Neurogenetics Laboratory, National Hospital for Neurology and Neurosurgery , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8498-5235","authenticated-orcid":false,"given":"Stephan","family":"Zuchner","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 , USA"},{"name":"John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine , Miami, FL 33136 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-5311","authenticated-orcid":false,"given":"Andrea","family":"Cortese","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-7777","authenticated-orcid":false,"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M","family":"Rossor","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8264-8676","authenticated-orcid":false,"given":"Matilde","family":"Laura","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-905X","authenticated-orcid":false,"given":"Mary M","family":"Reilly","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology , London WC1N 3BG , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2024090322142934400_awae064-B1","first-page":"93","article-title":"Sorting out the inherited neuropathies","volume":"7","author":"Reilly","year":"2007","journal-title":"Pract Neurol"},{"key":"2024090322142934400_awae064-B2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s12264-014-1475-7","article-title":"Intermediate Charcot-Marie-Tooth disease","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci Bull"},{"key":"2024090322142934400_awae064-B3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot-Marie-Tooth disease and related disorders: an evolving landscape","volume":"32","author":"Laur\u00e1","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"2024090322142934400_awae064-B4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2016-313960","article-title":"Peripheral neuropathy in complex inherited diseases: an approach to diagnosis","volume":"88","author":"Rossor","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B5","first-page":"10","article-title":"Strategy for genetic analysis in hereditary neuropathy","volume":"9","author":"Masingue","year":"2022","journal-title":"Rev Neurol (Paris)"},{"key":"2024090322142934400_awae064-B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443706","article-title":"Epidemiologic study of charcot-Marie-Tooth Disease: A systematic review","volume":"46","author":"Barreto","year":"2016","journal-title":"Neuroepidemiology"},{"key":"2024090322142934400_awae064-B7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"key":"2024090322142934400_awae064-B8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jnnp-2011-300285","article-title":"Charcot-Marie-Tooth disease in northern England","volume":"83","author":"Foley","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B9","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s00415-023-11559-8","article-title":"A meta-analysis on the prevalence of Charcot\u2013Marie\u2013Tooth disease and related inherited peripheral neuropathies","volume":"270","author":"Ma","year":"2023","journal-title":"J Neurol"},{"key":"2024090322142934400_awae064-B10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/brainsci11111447","article-title":"Challenges in treating Charcot-Marie-Tooth disease and related neuropathies: current management and future perspectives","volume":"11","author":"Pisciotta","year":"2021","journal-title":"Brain Sci"},{"key":"2024090322142934400_awae064-B11","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","article-title":"100,000 genomes pilot on rare-disease diagnosis in health care \u2014 Preliminary report","volume":"385","author":"Smedley","year":"2021","journal-title":"N Engl J Med."},{"key":"2024090322142934400_awae064-B12","author":"NHS Genomic Medicine Service"},{"key":"2024090322142934400_awae064-B13","author":"France Medecine Genomique 2025"},{"key":"2024090322142934400_awae064-B14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: A cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","article-title":"Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease","volume":"16","author":"Murphy","year":"2011","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jns.12084","article-title":"Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis","volume":"19","author":"Sadjadi","year":"2014","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.22836","article-title":"Innovative genomic collaboration using the GENESIS (GEM.app) platform","volume":"36","author":"Gonzalez","year":"2015","journal-title":"Hum Mutat"},{"key":"2024090322142934400_awae064-B18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2024090322142934400_awae064-B19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high-confidence variant calls: The genome analysis toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"2024090322142934400_awae064-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"2024090322142934400_awae064-B21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"2024090322142934400_awae064-B22","article-title":"ACGS best practice guidelines for variant classification in rare disease 2020","author":"Ellard","year":"2020","journal-title":"Assoc Clin Genom Sci."},{"key":"2024090322142934400_awae064-B23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","article-title":"Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes","volume":"52","author":"Cortese","year":"2020","journal-title":"Nat Genet"},{"key":"2024090322142934400_awae064-B24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","article-title":"Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia","volume":"51","author":"Cortese","year":"2019","journal-title":"Nat Genet"},{"key":"2024090322142934400_awae064-B25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp-2022-330223","article-title":"Beware next-generation sequencing gene panels as the first-line genetic test in Charcot-Marie-Tooth disease","volume":"94","author":"Record","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/323252","article-title":"Hereditary sensory neuropathy type I: haplotype analysis shows founders in southern England and Europe","volume":"69","author":"Nicholson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2024090322142934400_awae064-B27","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1093\/brain\/awad187","article-title":"Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants","volume":"146","author":"Record","year":"2023","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B28","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1212\/WNL.0000000000011528","article-title":"Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease","volume":"96","author":"Trasch\u00fctz","year":"2021","journal-title":"Neurology"},{"key":"2024090322142934400_awae064-B29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cphg.103","article-title":"A practical guide for structural variation detection in the human genome","volume":"107","author":"Yang","year":"2020","journal-title":"Curr Protoc Hum Genet"},{"key":"2024090322142934400_awae064-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bib\/bbac221","article-title":"A comprehensive benchmarking of WGS-based deletion structural variant callers","volume":"23","author":"Sarwal","year":"2022","journal-title":"Brief Bioinform"},{"key":"2024090322142934400_awae064-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-018-1404-6","article-title":"FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods","volume":"19","author":"Becker","year":"2018","journal-title":"Genome Biol"},{"key":"2024090322142934400_awae064-B32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fgene.2015.00138","article-title":"Whole-genome CNV analysis: advances in computational approaches","volume":"6","author":"Pirooznia","year":"2015","journal-title":"Front Genet"},{"key":"2024090322142934400_awae064-B33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s004390050812","article-title":"Genotype\/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene","volume":"103","author":"Ainsworth","year":"1998","journal-title":"Hum Genet"},{"key":"2024090322142934400_awae064-B34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jns.12117","article-title":"MFN2 deletion of exons 7 and 8: Founder mutation in the UK population","volume":"20","author":"Carr","year":"2015","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/gim.2015.124","article-title":"The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy","volume":"18","author":"Pehlivan","year":"2016","journal-title":"Genet Med"},{"key":"2024090322142934400_awae064-B36","first-page":"227","article-title":"Advancing Charcot-Marie-Tooth disease diagnostics, through the UK 100,000 genomes project","volume":"32","author":"Pipis","year":"2020","journal-title":"Med Genet."},{"key":"2024090322142934400_awae064-B37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/jpm12020212","article-title":"From negative to positive diagnosis: Structural variation could be the second mutation you are looking for in a recessive autosomal gene","volume":"12","author":"Pyromali","year":"2022","journal-title":"J Pers Med"},{"key":"2024090322142934400_awae064-B38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41431-023-01312-0","article-title":"Copy number variants from 4800 exomes contribute to \u223c7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies","volume":"31","author":"Pennings","year":"2023","journal-title":"Eur J Hum Genet."},{"key":"2024090322142934400_awae064-B39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s10038-019-0710-5","article-title":"Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease","volume":"65","author":"Mortreux","year":"2020","journal-title":"J Hum Genet"},{"key":"2024090322142934400_awae064-B40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-021-01201-x","article-title":"An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics","volume":"9","author":"Chintalaphani","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2024090322142934400_awae064-B41","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/brain\/awab072","article-title":"RFC1 expansions are a common cause of idiopathic sensory neuropathy","volume":"144","author":"Curr\u00f2","year":"2021","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awaa420","article-title":"An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy","volume":"144","author":"Pagnamenta","year":"2021","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-020-02017-z","article-title":"ExpansionHunter Denovo: A computational method for locating known and novel repeat expansions in short-read sequencing data","volume":"21","author":"Dolzhenko","year":"2020","journal-title":"Genome Biol"},{"key":"2024090322142934400_awae064-B44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","article-title":"Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: A retrospective diagnostic accuracy and prospective clinical validation study","volume":"21","author":"Iba\u00f1ez","year":"2022","journal-title":"Lancet Neurol"},{"key":"2024090322142934400_awae064-B45","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024090322142934400_awae064-B46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2014.4496","article-title":"Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease","volume":"72","author":"Akman H","year":"2015","journal-title":"JAMA Neurol"},{"key":"2024090322142934400_awae064-B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.676","article-title":"Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-Tooth phenotype with early onset symptoms","volume":"7","author":"Cassini","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2024090322142934400_awae064-B48","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1093\/brain\/awad203","article-title":"Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1","volume":"146","author":"Pipis","year":"2023","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B49","author":"Online Mendelian Inheritance in Man, OMIM\u00ae."},{"key":"2024090322142934400_awae064-B50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mgg3.630","article-title":"Clinical validity assessment of genes for inclusion in multi-gene panel testing: A systematic approach","volume":"7","author":"Zion","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2024090322142934400_awae064-B51","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ajhg.2017.04.015","article-title":"Evaluating the clinical validity of gene-disease associations: An evidence-based framework developed by the clinical genome resource","volume":"100","author":"Strande","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2024090322142934400_awae064-B52","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(14)61705-0","article-title":"Genetic diagnosis of developmental disorders in the DDD study: A scalable analysis of genome-wide research data","volume":"385","author":"Wright","year":"2015","journal-title":"Lancet."},{"key":"2024090322142934400_awae064-B53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/brain\/aww055","article-title":"De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease","volume":"139","author":"Motley","year":"2016","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.26501","article-title":"Heterozygous Seryl-tRNA synthetase 1 variants cause Charcot\u2013Marie\u2013Tooth disease","volume":"93","author":"He","year":"2023","journal-title":"Ann Neurol."},{"key":"2024090322142934400_awae064-B55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ana.26792","article-title":"SARS1 (SerRS) causing de novo dominant Charcot-Marie-Tooth disease with slow conduction","volume":"94","author":"Record","year":"2023","journal-title":"Ann Neurol"},{"key":"2024090322142934400_awae064-B56","first-page":"568","article-title":"Hereditary motor neuropathies","volume":"35","author":"Frasquet","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"2024090322142934400_awae064-B57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10072-020-04981-7","article-title":"Hereditary spastic paraplegia","volume":"42","author":"Murala","year":"2021","journal-title":"Neurol Sci."},{"issue":"1\u20132","key":"2024090322142934400_awae064-B58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2011.02.012","article-title":"Inherited mitochondrial neuropathies","volume":"304","author":"Finsterer","year":"2011","journal-title":"J Neurol Sci."},{"key":"2024090322142934400_awae064-B59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jamaneurol.2020.4911","article-title":"Adolescent-onset and adult-onset vitamin-responsive neurogenetic diseases: A review","volume":"78","author":"Mandia","year":"2021","journal-title":"JAMA Neurol"},{"key":"2024090322142934400_awae064-B60","doi-asserted-by":"crossref","first-page":"e16063","DOI":"10.1111\/ene.16063","article-title":"Mutations in alpha-B-crystallin cause autosomal dominant axonal Charcot\u2013Marie\u2013Tooth disease with congenital cataracts","volume":"31","author":"Cortese","year":"2023","journal-title":"Eur J Neurol"},{"key":"2024090322142934400_awae064-B61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/jnnp-2013-305049","article-title":"Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2","volume":"84","author":"Gonzalez","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B62","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jnnp-2020-323016","article-title":"Humans: The ultimate animal models","volume":"91","author":"Reilly","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B63","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2019.08.008","article-title":"Report of a novel ATP7A mutation causing distal motor neuropathy","volume":"29","author":"Gualandi","year":"2019","journal-title":"Neuromuscul Disord."},{"key":"2024090322142934400_awae064-B64","doi-asserted-by":"crossref","first-page":"104087","DOI":"10.1016\/j.ejmg.2020.104087","article-title":"ATP7A mutation with occipital horns and distal motor neuropathy: A continuum","volume":"63","author":"Fradin","year":"2020","journal-title":"Eur J Med Genet"},{"key":"2024090322142934400_awae064-B65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JND-190400","article-title":"A MT-ATP6 mutation causes a slowly progressive myeloneuropathy","volume":"6","author":"Bardakjian","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"2024090322142934400_awae064-B66","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ana.26063","article-title":"Mitochondrial DNA analysis from exome sequencing data improves diagnostic yield in neurological diseases","volume":"89","author":"Poole O","year":"2021","journal-title":"Ann Neurol"},{"issue":"S3","key":"2024090322142934400_awae064-B67","first-page":"352","article-title":"PNS 2022 abstract supplement","volume":"27","author":"Beijer","year":"2022","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B68","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00415-014-7289-8","article-title":"Whole-exome sequencing in patients with inherited neuropathies: Outcome and challenges","volume":"261","author":"Schabh\u00fcttl","year":"2014","journal-title":"J Neurol"},{"key":"2024090322142934400_awae064-B69","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/acn3.51190","article-title":"Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease","volume":"7","author":"R\u00f6nkk\u00f6","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2024090322142934400_awae064-B70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1516767","article-title":"Resolution of disease phenotypes resulting from multilocus genomic variation","volume":"376","author":"Posey","year":"2017","journal-title":"N Engl J Med."},{"key":"2024090322142934400_awae064-B71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ejhg.2016.146","article-title":"Clinical exome sequencing: Results from 2819 samples reflecting 1000 families","volume":"25","author":"Trujillano","year":"2017","journal-title":"Eur J Hum Genet."},{"key":"2024090322142934400_awae064-B72","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/brain\/awad050","article-title":"Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population","volume":"146","author":"Zanovello","year":"2023","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with Hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med."},{"key":"2024090322142934400_awae064-B74","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B75","doi-asserted-by":"crossref","first-page":"e021632","DOI":"10.1136\/bmjopen-2018-021632","article-title":"Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: Molecular spectrum delineation","volume":"8","author":"Bacquet","year":"2018","journal-title":"BMJ Open"},{"key":"2024090322142934400_awae064-B76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2018-318839","article-title":"Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan","volume":"90","author":"Yoshimura","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B77","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1212\/WNL.0000000000008672","article-title":"Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease","volume":"94","author":"Cortese","year":"2020","journal-title":"Neurology"},{"key":"2024090322142934400_awae064-B78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s10038-022-01031-2","article-title":"Clinical genetics of Charcot-Marie-Tooth disease","volume":"68","author":"Higuchi","year":"2022","journal-title":"J Hum Genet"},{"key":"2024090322142934400_awae064-B79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cge.13793","article-title":"Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies","volume":"98","author":"Padilha","year":"2020","journal-title":"Clin Genet"},{"key":"2024090322142934400_awae064-B80","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/humu.22143","article-title":"Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease","volume":"33","author":"Choi","year":"2012","journal-title":"Hum Mutat"},{"key":"2024090322142934400_awae064-B81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mgg3.126","article-title":"Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing","volume":"3","author":"Drew","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"2024090322142934400_awae064-B82","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.celrep.2015.07.023","article-title":"Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy","volume":"12","author":"Gonzaga-Jauregui","year":"2015","journal-title":"Cell Rep"},{"key":"2024090322142934400_awae064-B83","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1111\/ene.15024","article-title":"Genotype and phenotype distribution of 435 patients with Charcot-Marie-Tooth disease from central south China","volume":"28","author":"Xie","year":"2021","journal-title":"Eur J Neurol"},{"key":"2024090322142934400_awae064-B84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ene.15860","article-title":"Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: Data from the national CMT registry","volume":"30","author":"Pisciotta","year":"2023","journal-title":"Eur J Neurol"},{"key":"2024090322142934400_awae064-B85","doi-asserted-by":"crossref","first-page":"fcad139","DOI":"10.1093\/braincomms\/fcad139","article-title":"Whole-genome sequencing in clinically diagnosed Charcot-Marie-Tooth disease undiagnosed by whole-exome sequencing","volume":"5","author":"Kim","year":"2023","journal-title":"Brain Commun"},{"key":"2024090322142934400_awae064-B86","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1038\/s41467-022-32908-7","article-title":"Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing","volume":"13","author":"Macken","year":"2022","journal-title":"Nat Commun."},{"key":"2024090322142934400_awae064-B87","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00415-022-11026-w","article-title":"Complex hereditary peripheral neuropathies caused by novel variants in mitochondrial-related nuclear genes","volume":"269","author":"Hiramatsu","year":"2022","journal-title":"J Neurol"},{"key":"2024090322142934400_awae064-B88","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1093\/brain\/awad254","article-title":"Neuromuscular disease genetics in underrepresented populations: Increasing data diversity","volume":"146","author":"Wilson","year":"2023","journal-title":"Brain"},{"key":"2024090322142934400_awae064-B89","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acn3.50797","article-title":"Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan","volume":"6","author":"Hsu","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2024090322142934400_awae064-B90","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/cge.13616","article-title":"Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot-Marie-Tooth disease","volume":"96","author":"Chen","year":"2019","journal-title":"Clin Genet"},{"key":"2024090322142934400_awae064-B91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jns.12489","article-title":"Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review","volume":"27","author":"Yalcouy\u00e9","year":"2022","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B92","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1055\/s-0043-1770348","article-title":"Charcot-Marie-Tooth disease: From historical landmarks in Brazil to current care perspectives","volume":"81","author":"Cavalcanti","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"2024090322142934400_awae064-B93","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jnnp-2022-330769","article-title":"Clinical phenotypic diversity of NOTCH2NLC -related disease in the largest case series of inherited peripheral neuropathy in Japan","volume":"94","author":"Ando","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024090322142934400_awae064-B94","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41436-020-0924-0","article-title":"Assessing non-Mendelian inheritance in inherited axonopathies","volume":"22","author":"Bis-Brewer","year":"2020","journal-title":"Genet Med"},{"key":"2024090322142934400_awae064-B95","doi-asserted-by":"crossref","first-page":"e3163","DOI":"10.1212\/WNL.0000000000011132","article-title":"The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME","volume":"95","author":"Senderek","year":"2020","journal-title":"Neurology"},{"key":"2024090322142934400_awae064-B96","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0000000000000700","article-title":"The spectrum of axonopathies: From CMT2 to HSP","volume":"83","author":"Fridman","year":"2014","journal-title":"Neurology"},{"key":"2024090322142934400_awae064-B97","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41576-020-0236-x","article-title":"Long-read human genome sequencing and its applications","volume":"21","author":"Logsdon","year":"2020","journal-title":"Nat Rev Genet"},{"key":"2024090322142934400_awae064-B98","doi-asserted-by":"crossref","first-page":"e200036","DOI":"10.1212\/NXG.0000000000200036","article-title":"Whole-Genome and long-read sequencing identify a novel mechanism in RFC1 resulting in CANVAS syndrome","volume":"8","author":"King","year":"2022","journal-title":"Neurol Genet"},{"key":"2024090322142934400_awae064-B99","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jns.12485","article-title":"Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy","volume":"27","author":"Grosz","year":"2022","journal-title":"J Peripher Nerv Syst."},{"key":"2024090322142934400_awae064-B100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.1936","article-title":"Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics","volume":"10","author":"Dai","year":"2022","journal-title":"Mol Genet Genomic Med"},{"key":"2024090322142934400_awae064-B101","first-page":"1","article-title":"ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10","volume":"3","author":"Torres CA","year":"2022","journal-title":"Hum Genet Genom Adv"},{"key":"2024090322142934400_awae064-B102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1126\/science.1188021","article-title":"A draft sequence of the neandertal genome","volume":"328","author":"Green","year":"2010","journal-title":"Science"},{"key":"2024090322142934400_awae064-B103","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41576-020-0210-7","article-title":"Pan-genomics in the human genome era","volume":"21","author":"Sherman","year":"2020","journal-title":"Nat Rev Genet"},{"key":"2024090322142934400_awae064-B104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-022-04601-8","article-title":"The human pangenome project: a global resource to map genomic diversity","volume":"604","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"2024090322142934400_awae064-B105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41582-021-00455-2","article-title":"Applying genomic and transcriptomic advances to mitochondrial medicine","volume":"17","author":"Macken","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"2024090322142934400_awae064-B106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15824","article-title":"Genetic diagnosis of Mendelian disorders via RNA sequencing","volume":"8","author":"Kremer","year":"2017","journal-title":"Nat Commun"},{"key":"2024090322142934400_awae064-B107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXG.0000000000000496","article-title":"Isoform-specific loss of dystonin causes hereditary motor and sensory neuropathy","volume":"6","author":"Motley","year":"2020","journal-title":"Neurol Genet"},{"key":"2024090322142934400_awae064-B108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcab253","article-title":"Dissection of TAF1 neuronal splicing and implications for neurodegeneration in X-linked dystonia-parkinsonism","volume":"3","author":"Capponi","year":"2021","journal-title":"Brain Commun"},{"key":"2024090322142934400_awae064-B109","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/brain\/awac424","article-title":"Novel gene\u2013intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy","volume":"146","author":"Cutrupi","year":"2022","journal-title":"Brain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae064\/58749950\/awae064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/9\/3144\/59004050\/awae064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/9\/3144\/59004050\/awae064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T06:48:52Z","timestamp":1725432532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/9\/3144\/7628356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":109,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,3,14]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae064","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,3,14]]}}}